A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Idiopathic Short Stature

In brief

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).

Key facts

Study ID
NCT06382155
Run by
BioMarin Pharmaceutical
People needed
100
Starts
2024-10-21
Expected to finish
2036-12-01
Last updated by the study team
2026-05-22

Who can join

Age: 3 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.